EUSOL Biotech Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced operating loss was TWD 59.703 million compared to TWD 55.931 million a year ago. Net loss was TWD 59.111 million compared to TWD 49.739 million a year ago. Basic loss per share was TWD 0.47 compared to TWD 0.4 a year ago.